| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| LIXTE BIOTECHNOLOGY HOLDINGS, INC. | Vice President and CFO | Stock Options | 200,000 | 06 Nov 2022 | Direct | ||
| Guardion Health Sciences, Inc. | Director | Employee Stock Option (right to buy) | 334 | 30 Jun 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000149315223023465-weingarten-robert-n-2023-06-30 | Guardion Health Sciences, Inc. | 30 Jun 2023 | 1 | $0 | 4 | Director | 05 Jul 2023, 17:00 |
| LIXT | LIXTE BIOTECHNOLOGY HOLDINGS, INC. | 06 Nov 2022 | 1 | $0 | 4 | Vice President and CFO | 09 Nov 2022, 16:00 |
| /report/000149315222017373-weingarten-robert-n-2022-06-16 | Guardion Health Sciences, Inc. | 16 Jun 2022 | 1 | $0 | 4 | Director | 21 Jun 2022, 16:10 |
| /report/000149315221020894-weingarten-robert-n-2021-08-20 | Guardion Health Sciences, Inc. | 20 Aug 2021 | 1 | +$11,400 | 4 | Director | 23 Aug 2021, 06:10 |
| /report/000149315221015932-weingarten-robert-n-2021-06-30 | Guardion Health Sciences, Inc. | 30 Jun 2021 | 1 | $0 | 4 | Director | 02 Jul 2021, 08:30 |